Paragonix SherpaPak™1, 2, 3, 4
Cardiac Transport System

A cold storage device intended to standardize and control donor heart preservation and transport

1 Patents issued and pending.
2 Caution: Federal (US) law restricts this device to sale by or an the order of a licensed health care practitioner.
3 Please refer to Instructions for Use for full prescribing information.
4 Cleared indication is for 4 hour use. Data on File.

  • Paragonix SherpaPak™ insulated shipper:
    Thermal stability validated for 12+ hours at ambient and extreme temperatures
  • Disposable cold packs:
    Non-toxic, engineered for high latent heat storage in the 4-8°C range
  • Sterile, rigid storage canister set:
    Inner organ canister holds 4 L with real-time preservation temperature sensor

Indicated for donor organ heart preservation and transportation

  • Conventional ice chests are an uncontrolled method of donor organ transport
  • All components are fully validated
  • Use with any FDA-cleared, effective preservation solution indicated for donor hearts

Maintains safe organ preservation temperature

  • No temperature gradients across donor hearts
  • Continuously measures and displays temperature during storage and transport
  • Storage temperature is validated for 12+ hours

Complete immersion of donor organ in solution

  • Donor heart is fully immersed in preservation solution
  • Two rigid sterile canisters plus Paragonix SherpaPak™ shipper provide triple barrier protection of organs
  • Meets or exceeds UNOS/AOPO Organ Packaging Guidelines

Monitor and record organ temperature with Paragonix SherpaTrak™

  • Continuously measures and displays temperature during storage and transport
  • Temperature report downloads to your phone or tablet
  • Communicates via Bluetooth with mobile devices


Indications of Use:

The Paragonix SherpaPak™ Cardiac Transport System is intended to be used for the static hypothermic preservation of hearts during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the heart.

The intended organ storage time for the Paragonix SherpaPak™ Cardiac Transport System is up to 4 hours.

Donor hearts exceeding clinically accepted static hypothermic preservation times should be evaluated by the transplant surgeon to determine transplantability in accordance with accepted clinical guidelines and in the best medical interest of the intended recipient.


Please review the instructions for use for complete prescribing information including indications, contraindications, warnings and precautions.

If you would like further information on this or or any other Paragonix product, please complete this short form and someone will be in touch with you shortly